Liveleaf Holdings LLC
Records under this name other than the patents Liveleaf Holdings LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,822,544 | Tannin Formulation for Treating Gastrointestinal Spasms in a Subject Having Colorectal Cancer Lapsed on the fee record Ended Sep 2, 2026 · High confidence | Lapsed on the fee record | Ended Sep 2, 2026 | High confidence |
| US 8,822,545 | Tannin Formulation for Treating Gastrointestinal Spasms Triggered by Stress Lapsed on the fee record Ended Sep 2, 2026 · High confidence | Lapsed on the fee record | Ended Sep 2, 2026 | High confidence |
| US 8,809,399 | Methods of Treating Gastrointestinal Spasms Triggered by Stress Lapsed on the fee record Ended Aug 19, 2026 · High confidence | Lapsed on the fee record | Ended Aug 19, 2026 | High confidence |
| US 8,772,350 | Methods of Treating Gastrointestinal Spasms in a Subject Having Diverticulitis Lapsed on the fee record Ended Jul 8, 2026 · High confidence | Lapsed on the fee record | Ended Jul 8, 2026 | High confidence |
| US 8,772,351 | Tannin Formulation for Treating Gastrointestinal Spasms in a Subject Having Diverticulitis Lapsed on the fee record Ended Jul 8, 2026 · High confidence | Lapsed on the fee record | Ended Jul 8, 2026 | High confidence |
| US 8,772,352 | Methods of Treating Gastrointestinal Spasms in a Subject Having Colorectal Cancer Lapsed on the fee record Ended Jul 8, 2026 · High confidence | Lapsed on the fee record | Ended Jul 8, 2026 | High confidence |
| US 8,765,818 | Tannin Formulation for Treating Gastrointestinal Spasms in a Subject Having Crohn's Disease or Ulcerative Colitis Lapsed on the fee record Ended Jul 1, 2026 · High confidence | Lapsed on the fee record | Ended Jul 1, 2026 | High confidence |
| US 8,722,040 | Site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites Lapsed on the fee record Ended May 13, 2026 · Medium confidence | Lapsed on the fee record | Ended May 13, 2026 | Medium confidence |
| US 8,716,351 | Methods of Treating Gastrointestinal Spasms Lapsed on the fee record Ended May 6, 2026 · High confidence | Lapsed on the fee record | Ended May 6, 2026 | High confidence |
| US 8,716,353 | Methods of Treating Gastrointestinal Spasms in a Subject Having Crohn's Disease or Ulcerative Colitis Lapsed on the fee record Ended May 6, 2026 · High confidence | Lapsed on the fee record | Ended May 6, 2026 | High confidence |